Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
367
-
Total 13F shares, excl. options
-
211M
-
Shares change
-
+4.91M
-
Total reported value, excl. options
-
$3.84B
-
Value change
-
+$78.9M
-
Put/Call ratio
-
0.75
-
Number of buys
-
230
-
Number of sells
-
-161
-
Price
-
$18.21
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q2 2025
444 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q2 2025.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 367 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 211M shares
of 237M outstanding shares and own 89.11% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (36.5M shares), VANGUARD GROUP INC (21.4M shares), Invesco Ltd. (12.8M shares), STATE STREET CORP (12.1M shares), GEODE CAPITAL MANAGEMENT, LLC (5.91M shares), Nuveen, LLC (5.56M shares), DIMENSIONAL FUND ADVISORS LP (4.76M shares), AMERICAN CENTURY COMPANIES INC (4.61M shares), Allspring Global Investments Holdings, LLC (3.32M shares), and Thrivent Financial for Lutherans (3.32M shares).
This table shows the top 367 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.